Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock factor binding protein 1 pseudogene 1 (HSBP1P1) is a pseudogene, meaning it is a genomic DNA sequence similar to a normal gene but non-functional in terms of protein coding. Recent research suggests that some pseudogenes, including HSBP1P1, may have regulatory roles at the RNA level. Specifically, HSBP1P1 is overexpressed in renal cell carcinoma, where it is associated with tumor progression and poor prognosis. It functions as a competing endogenous RNA in the cytoplasm, acting as a miRNA sponge (notably for miR-296-5p), thereby influencing the expression of oncogenic regulators such as high-mobility group A1 (HMGA1)[2]. Currently, HSBP1P1 is not a canonical drug target, but its expression patterns and gene regulatory activity make it a candidate biomarker in cancer biology.
Not applicable for therapeutics; as a miRNA sponge, it modulates the availability and function of specific miRNAs, which then regulate expression of protein-coding genes (e.g., miR-296-5p/HMGA1 axis in RCC)[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock factor binding protein 1 pseudogene 1 (HSBP1P1).